Ropes & Gray grows FDA practice
Executive Summary
Bennett, Turner & Coleman D.C. law firm will merge into Ropes & Gray's Health and Life Sciences Practices. Ropes & Gray, which employs two attorneys in its FDA practice, will gain BT&C's 11 attorneys with expertise in FDA regulatory issues. During a House Commerce/Oversight Subcommittee hearing on ImClone's Erbitux, a Bristol exec testified that Bennett, Turner & Coleman partner Alan Bennett informed him that a refuse-to-file letter from FDA was imminent (1"The Pink Sheet" June 17, p. 5)...
You may also be interested in...
Erbitux Hearing Puts Focus On Pre-Approval Promotion, FDA Communication
The House Energy & Commerce Committee is interested in looking further into FDA's authority to "rein in" pre-approval promotions
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.